Stay updated on BBI608 Pembrolizumab Combination: Clinical Trial
Sign up to get notified when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.

Latest updates to the BBI608 Pembrolizumab Combination: Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a maintenance patch to the study record page. No study data or user-facing content appears to have changed.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page revision tag was updated to v3.6.2, indicating a small version update. No substantive changes to study content are indicated.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedEnrollment status updated to indicate no longer recruiting; new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the revision history updated to v3.6.0, reflecting a formatting change to the Intervention/Treatment heading.SummaryDifference0.6%

- Check33 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor update to the page. No substantive study content appears to be affected.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a deployment update without visible changes to content or features.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision was updated to v3.5.3, signaling a minor system update; no changes to study details, enrollment, or other visible content.SummaryDifference0.1%

Stay in the know with updates to BBI608 Pembrolizumab Combination: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.